8-143921001-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_201384.3(PLEC):​c.8820C>G​(p.Asp2940Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0158 in 1,612,998 control chromosomes in the GnomAD database, including 2,353 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D2940V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.070 ( 1201 hom., cov: 33)
Exomes 𝑓: 0.010 ( 1152 hom. )

Consequence

PLEC
NM_201384.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.799

Publications

7 publications found
Variant links:
Genes affected
PLEC (HGNC:9069): (plectin) Plectin is a prominent member of an important family of structurally and in part functionally related proteins, termed plakins or cytolinkers, that are capable of interlinking different elements of the cytoskeleton. Plakins, with their multi-domain structure and enormous size, not only play crucial roles in maintaining cell and tissue integrity and orchestrating dynamic changes in cytoarchitecture and cell shape, but also serve as scaffolding platforms for the assembly, positioning, and regulation of signaling complexes (reviewed in PMID: 9701547, 11854008, and 17499243). Plectin is expressed as several protein isoforms in a wide range of cell types and tissues from a single gene located on chromosome 8 in humans (PMID: 8633055, 8698233). Until 2010, this locus was named plectin 1 (symbol PLEC1 in human; Plec1 in mouse and rat) and the gene product had been referred to as "hemidesmosomal protein 1" or "plectin 1, intermediate filament binding 500kDa". These names were superseded by plectin. The plectin gene locus in mouse on chromosome 15 has been analyzed in detail (PMID: 10556294, 14559777), revealing a genomic exon-intron organization with well over 40 exons spanning over 62 kb and an unusual 5' transcript complexity of plectin isoforms. Eleven exons (1-1j) have been identified that alternatively splice directly into a common exon 2 which is the first exon to encode plectin's highly conserved actin binding domain (ABD). Three additional exons (-1, 0a, and 0) splice into an alternative first coding exon (1c), and two additional exons (2alpha and 3alpha) are optionally spliced within the exons encoding the acting binding domain (exons 2-8). Analysis of the human locus has identified eight of the eleven alternative 5' exons found in mouse and rat (PMID: 14672974); exons 1i, 1j and 1h have not been confirmed in human. Furthermore, isoforms lacking the central rod domain encoded by exon 31 have been detected in mouse (PMID:10556294), rat (PMID: 9177781), and human (PMID: 11441066, 10780662, 20052759). The short alternative amino-terminal sequences encoded by the different first exons direct the targeting of the various isoforms to distinct subcellular locations (PMID: 14559777). As the expression of specific plectin isoforms was found to be dependent on cell type (tissue) and stage of development (PMID: 10556294, 12542521, 17389230) it appears that each cell type (tissue) contains a unique set (proportion and composition) of plectin isoforms, as if custom-made for specific requirements of the particular cells. Concordantly, individual isoforms were found to carry out distinct and specific functions (PMID: 14559777, 12542521, 18541706). In 1996, a number of groups reported that patients suffering from epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) lacked plectin expression in skin and muscle tissues due to defects in the plectin gene (PMID: 8698233, 8941634, 8636409, 8894687, 8696340). Two other subtypes of plectin-related EBS have been described: EBS-pyloric atresia (PA) and EBS-Ogna. For reviews of plectin-related diseases see PMID: 15810881, 19945614. Mutations in the plectin gene related to human diseases should be named based on the position in NM_000445 (variant 1, isoform 1c), unless the mutation is located within one of the other alternative first exons, in which case the position in the respective Reference Sequence should be used. [provided by RefSeq, Aug 2011]
PLEC Gene-Disease associations (from GenCC):
  • epidermolysis bullosa simplex
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • epidermolysis bullosa simplex 5A, Ogna type
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, Genomics England PanelApp
  • autosomal recessive limb-girdle muscular dystrophy type 2Q
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • congenital myasthenic syndrome
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • epidermolysis bullosa simplex 5B, with muscular dystrophy
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Genomics England PanelApp
  • epidermolysis bullosa simplex 5C, with pyloric atresia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • epidermolysis bullosa simplex with nail dystrophy
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia
  • autosomal recessive limb-girdle muscular dystrophy
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • aplasia cutis congenita
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cholestasis
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015553236).
BP6
Variant 8-143921001-G-C is Benign according to our data. Variant chr8-143921001-G-C is described in ClinVar as Benign. ClinVar VariationId is 129960.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.23 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLECNM_201384.3 linkc.8820C>G p.Asp2940Glu missense_variant Exon 32 of 32 ENST00000345136.8 NP_958786.1
PLECNM_201378.4 linkc.8778C>G p.Asp2926Glu missense_variant Exon 32 of 32 ENST00000356346.7 NP_958780.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLECENST00000345136.8 linkc.8820C>G p.Asp2940Glu missense_variant Exon 32 of 32 1 NM_201384.3 ENSP00000344848.3
PLECENST00000356346.7 linkc.8778C>G p.Asp2926Glu missense_variant Exon 32 of 32 1 NM_201378.4 ENSP00000348702.3

Frequencies

GnomAD3 genomes
AF:
0.0696
AC:
10593
AN:
152160
Hom.:
1193
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.234
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0285
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00188
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00464
Gnomad OTH
AF:
0.0606
GnomAD2 exomes
AF:
0.0197
AC:
4904
AN:
248532
AF XY:
0.0156
show subpopulations
Gnomad AFR exome
AF:
0.244
Gnomad AMR exome
AF:
0.0138
Gnomad ASJ exome
AF:
0.00129
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00216
Gnomad NFE exome
AF:
0.00481
Gnomad OTH exome
AF:
0.00959
GnomAD4 exome
AF:
0.0102
AC:
14897
AN:
1460720
Hom.:
1152
Cov.:
76
AF XY:
0.00905
AC XY:
6574
AN XY:
726738
show subpopulations
African (AFR)
AF:
0.251
AC:
8394
AN:
33480
American (AMR)
AF:
0.0150
AC:
672
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00107
AC:
28
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39698
South Asian (SAS)
AF:
0.000371
AC:
32
AN:
86258
European-Finnish (FIN)
AF:
0.00222
AC:
116
AN:
52276
Middle Eastern (MID)
AF:
0.0156
AC:
90
AN:
5768
European-Non Finnish (NFE)
AF:
0.00405
AC:
4507
AN:
1112000
Other (OTH)
AF:
0.0175
AC:
1056
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
956
1912
2867
3823
4779
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
318
636
954
1272
1590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0698
AC:
10632
AN:
152278
Hom.:
1201
Cov.:
33
AF XY:
0.0675
AC XY:
5029
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.234
AC:
9718
AN:
41528
American (AMR)
AF:
0.0284
AC:
434
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4822
European-Finnish (FIN)
AF:
0.00188
AC:
20
AN:
10622
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00463
AC:
315
AN:
68034
Other (OTH)
AF:
0.0600
AC:
127
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
438
876
1313
1751
2189
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0226
Hom.:
91
Bravo
AF:
0.0802
TwinsUK
AF:
0.00566
AC:
21
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.214
AC:
927
ESP6500EA
AF:
0.00457
AC:
39
ExAC
AF:
0.0237
AC:
2872
Asia WGS
AF:
0.0160
AC:
55
AN:
3478
EpiCase
AF:
0.00420
EpiControl
AF:
0.00516

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jan 13, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Asp3077Glu in exon 32 of PLEC: This variant is not expected to have clinical s ignificance because it has been identified in 21.4% (927/4330) of African Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs58308209). -

Mar 25, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Jun 18, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Epidermolysis bullosa simplex, Ogna type;C2677349:Epidermolysis bullosa simplex 5C, with pyloric atresia;C2931072:Epidermolysis bullosa simplex 5B, with muscular dystrophy;C3150989:Autosomal recessive limb-girdle muscular dystrophy type 2Q;C4225309:Epidermolysis bullosa simplex with nail dystrophy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
15
DANN
Benign
0.88
DEOGEN2
Benign
0.063
.;.;.;.;T;.;.;.;.;.
Eigen
Benign
-0.53
Eigen_PC
Benign
-0.37
FATHMM_MKL
Benign
0.67
D
LIST_S2
Benign
0.72
T;T;T;T;T;T;T;T;T;T
MetaRNN
Benign
0.0016
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.94
.;.;.;.;L;.;.;.;.;.
PhyloP100
0.80
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.0
N;N;N;N;N;N;N;N;.;N
REVEL
Benign
0.069
Sift
Benign
0.18
T;T;T;T;T;T;T;T;.;T
Sift4G
Benign
0.46
T;T;T;T;T;T;T;T;.;T
Polyphen
0.10
B;B;B;B;B;B;B;B;.;.
Vest4
0.15
MutPred
0.29
.;.;.;.;Gain of helix (P = 0.0325);.;.;.;.;.;
ClinPred
0.0056
T
GERP RS
2.0
RBP_binding_hub_radar
1.0
RBP_regulation_power_radar
2.8
Varity_R
0.033
gMVP
0.29
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58308209; hg19: chr8-144995169; API